Rapport Therapeutics, Inc. Common Stock
Rapport Therapeutics, Inc. Common Stock (RAPP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RAPP · as of Jun 8, 2026
Key Statistics
Explore Rapport Therapeutics, Inc. Common Stock Data
rapp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 100.0%
The RAPP analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $54.00, representing +48.25% upside from the current price of $36.42.
Competitors & Peers
rapp competitorsRAPP
ANAB
BBOT
KOD
MNMD
NRIXStock Performance
Full HistoryAbout Rapport Therapeutics, Inc. Common Stock
Rapport Therapeutics, Inc. Common Stock Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering fro…
what is rapport therapeutics, inc. common stock · rapp stock overview · rapport therapeutics, inc. common stock company profile · who is rapport therapeutics, inc. common stock ceo · rapp NASDAQ · rapport therapeutics, inc. common stock headquarters · rapport therapeutics, inc. common stock business segments
About Stock Overview & Key Data
Rapport Therapeutics, Inc. Common Stock (RAPP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 7, 2024. As of the latest trading session, RAPP stock price is $36.42, with a market capitalization of $1.3B. The stock has returned +187.18% over the past 12 months and +20.30% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Rapport Therapeutics, Inc. Common Stock stock is Buy, with an average 12-month price target of $54.00. In fiscal year 2025, Rapport Therapeutics, Inc. Common Stock reported revenue of — and net income of -$111.5M. For detailed data — including Rapport Therapeutics, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Rapport Therapeutics, Inc. Common Stock (RAPP) stock price is $36.42. The stock is traded on NASDAQ under the ticker symbol RAPP. The 52-week range is $10.51 – $42.27.